Cargando…
Tumor Microenvironment in Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: Interaction between Tumors and Immune Cells, and Potential Effects of Neuroendocrine Differentiation on the Tumor Microenvironment
SIMPLE SUMMARY: The neuroendocrine differentiation of tumors is considered to influence the tumor microenvironment through the secretion of various hormones or growth factors. However, cases of neuroendocrine and non-neuroendocrine neoplasms are difficult to compare because of the potential differen...
Autores principales: | Tsunokake, Junichi, Fujishima, Fumiyoshi, Watanabe, Hirofumi, Sato, Ikuro, Miura, Koh, Sakamoto, Kazuhiro, Suzuki, Hiroyoshi, Sawai, Takashi, Itakura, Yuko, Hoshi, Tatsuya, Kunimitsu, Atsushi, Yamauchi, Takuro, Akaishi, Ryujiro, Ozawa, Yohei, Fukutomi, Toshiaki, Okamoto, Hiroshi, Sato, Chiaki, Taniyama, Yusuke, Kamei, Takashi, Sasano, Hironobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100554/ https://www.ncbi.nlm.nih.gov/pubmed/35565281 http://dx.doi.org/10.3390/cancers14092152 |
Ejemplares similares
-
Necroptosis in Esophageal Squamous Cell Carcinoma: An Independent Prognostic Factor and Its Correlation with Tumor-Infiltrating Lymphocytes
por: Yamauchi, Takuro, et al.
Publicado: (2021) -
HO‐1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy
por: Akaishi, Ryujiro, et al.
Publicado: (2021) -
Correlation between TXNRD1/HO-1 expression and response to neoadjuvant chemoradiation therapy in patients with esophageal squamous cell carcinoma
por: Akaishi, Ryujiro, et al.
Publicado: (2022) -
Thoracoscopic esophagectomy for esophageal carcinoma after peroral endoscopic myotomy for esophageal achalasia: a case report
por: Tsunokake, Junichi, et al.
Publicado: (2021) -
Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy
por: Zhou, Yuhang, et al.
Publicado: (2023)